正常高值甲状旁腺激素与心血管及全因死亡:ELSA-Brasil研究中的性别与年龄差异
基于ELSA-Brasil队列4736名中年参与者(平均51.7岁,55%女性),中位随访11.2年,基线PTH>56 pg/mL独立关联心血管死亡(sHR 1.92)和全因死亡(HR 1.61)。心血管死亡风险增加仅见于女性和≤64岁成人,全因死亡风险增加在两性及两个年龄组中一致。
要点
- PTH>56 pg/mL与心血管死亡(sHR 1.92)和全因死亡(HR 1.61)风险升高独立相关。
- 心血管死亡风险增加仅见于女性(sHR 2.79)和≤64岁成人(sHR 1.80)。
- 全因死亡风险增加在两性及≤64岁和>64岁组中均一致。
核心结论
- 在社区中年人群中,处于参考范围高端的PTH水平与心血管和全因死亡风险升高相关。
- 心血管死亡风险增加仅限于女性和较年轻成人,提示PTH可能作为性别敏感的早期心血管代谢风险生物标志物。
研究设计与样本
- ELSA-Brasil前瞻性队列研究,纳入4736名参与者(平均年龄51.7岁,55%女性),中位随访11.2年。
- 基线血清PTH采用电化学发光免疫分析法测定。
- 全因死亡采用Cox回归报告HR,心血管死亡采用Fine-Gray竞争风险模型报告sHR,并校正总钙及其他相关协变量。
主要发现
- 基线PTH>56 pg/mL独立关联心血管死亡(sHR 1.92;95% CI 1.22-3.01)和全因死亡(HR 1.61;95% CI 1.25-2.07)。
- 女性中PTH升高与心血管死亡风险增加179%相关(sHR 2.79;95% CI 1.37-5.70),男性中无显著关联。
- ≤64岁成人中PTH升高与心血管死亡风险增加相关(sHR 1.80;95% CI 1.05-3.09),>64岁成人中无显著关联。
- 全因死亡方面,PTH>56 pg/mL在女性(HR 1.75;95% CI 1.15-2.66)和男性(HR 1.59;95% CI 1.16-2.19)中均与风险升高相关,且≤64岁和>64岁两个年龄组中关联一致。
临床怎么用
- 在中年社区人群中,关注参考范围内偏高的PTH水平可能有助于识别心血管死亡风险较高的个体。
- 女性和较年轻成人中PTH与心血管死亡的关联更强,提示PTH作为性别敏感早期风险标志物的潜在价值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Elevated parathyroid hormone (PTH) levels have been linked to higher cardiovascular (CV) and all-cause mortality in individuals with hyperparathyroidism or high-risk conditions (individuals with a mean age of 75-85 years and patients undergoing coronary angiography). However, it remains uncertain whether sex- and age-related differences influence these associations among normocalcemic and middle-aged adults from the general population. METHODS: We analyzed 4736 participants from the ELSA-Brasil study (mean age, 51.7 years; 55% females), followed for a median of 11.2 years. Baseline serum PTH was measured by electrochemiluminescence immunoassay. Associations of PTH with outcomes were assessed using Cox regression for all-cause mortality, reporting hazard ratios (HRs), and Fine-Gray models for CV mortality, accounting for competing risks and reporting subdistribution hazard ratios (sHRs), adjusted for total calcium, and other relevant covariates. RESULTS: A baseline PTH concentration >56 pg/mL was independently associated with higher CV mortality (sHR 1.92; 95% CI 1.22-3.01) and all-cause mortality (HR 1.61; 95% CI 1.25-2.07). Sex- and age-stratified analyses showed that females with elevated PTH had a 179% increased CV mortality risk (sHR 2.79; 95% CI 1.37-5.70), whereas no significant association was seen in males. Elevated PTH was also associated with increased CV mortality in adults ≤64 years (sHR 1.80; 95% CI 1.05-3.09) but not in older individuals. For all-cause mortality, PTH >56 pg/mL conferred a higher risk in both females (HR 1.75; 95% CI 1.15-2.66) and males (HR 1.59; 95% CI 1.16-2.19), with consistent associations across both age groups (≤64 and >64 years). CONCLUSION: In this large, community-based cohort, PTH levels at the upper end of the reference range were associated with greater CV and all-cause mortality. The excess CV risk was restricted to females and younger adults, suggesting that PTH may serve as an early, sex-sensitive biomarker of cardiometabolic risk.
引用
- Okubo J, Kawahara EZ, Mori GH, et al. High normal parathyroid hormone and cardiovascular and total mortality: sex and age disparities in the ELSA-Brasil study. J Clin Endocrinol Metab. 2026. PMID: 41735732. doi:10.1210/clinem/dgag076
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。